Monday, August 1, 2011

Ontario Institute for Cancer Research Receives $420 Million Over Five Years for Important Cancer Research in Ontario Read more: Ontario Institute for Cancer Research Receives $420 Million Over Five Years for Important Cancer Research in Ontario


TORONTO, July 26, 2011 /PRNewswire/ -- The Ontario Institute for Cancer Research (OICR) will receive $420 million over five years from the Government of Ontario to continue its research into the prevention, early detection, diagnosis and treatment of cancer. The Institute will also occupy two floors of Phase II of the MaRS Centre in addition to its current laboratories and offices at its headquarters in the MaRS Centre. The announcement was made today by Dr. Tom Hudson, President and Scientific Director.
Today's announcement means continued support for the Institute in fulfilling the ambitious goals set out in its second Strategic Plan for 2010-2015, which focuses on the adoption of more personalized approaches to cancer diagnosis and treatment. OICR's current research activities in genomics and bioinformatics will be expanded in the new space in Phase II, allowing the Institute to increase its capacity to make new discoveries and move them out of the laboratory into the clinic for the benefit of patients. The funding will also enable the Ontario Health Study to complete its recruitment plans for the Study which will lead to better prevention of cancer and other chronic diseases.


Read more: Ontario Institute for Cancer Research Receives $420 Million Over Five Years for Important Cancer Research in Ontario - FierceBiotech http://www.fiercebiotech.com/press-releases/ontario-institute-cancer-research-receives-420-million-over-five-years-impo#ixzz1TnYjBOiS

No comments:

Post a Comment